NuChem Sciences
NuChem Sciences is a contract research organization based in Montréal that specializes in drug discovery services for the pharmaceutical and biotechnology sectors. It serves a diverse clientele that includes biotech companies, pharmaceutical firms, and academic research laboratories across North America. The organization offers a wide array of services in medicinal chemistry and drug discovery biology, encompassing fragment screening, structure-activity relationship design, and computational drug design. By providing relevant data and expertise, NuChem Sciences aims to support its clients in advancing their projects efficiently in various therapeutic areas such as inflammation, diabetes, cancer, obesity, infectious diseases, and pain management.
IniXium, established in 2014, is a customer-focused contract research organization (CRO) that serves the global biotechnology and pharmaceutical industries. The company specializes in providing essential expertise in structural biology, offering services such as the production and biophysical characterization of recombinant proteins, protein crystallography, and fragment screening. By delivering critical data during the early phases of drug discovery, IniXium supports its clients in advancing their research projects effectively.
OmegaChem is a contract research organization focused on drug discovery and fine chemical manufacturing for the pharmaceutical industry. The company specializes in custom synthesis, process chemistry, and research and development contracts that assess biological activities. By providing these services, OmegaChem helps clients enhance yields, streamline processing steps, and tailor the quantities and types of reagents used. This approach not only reduces manufacturing costs for specific molecules but also improves the scalability and safety of synthetic processes.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.